REDS.ST Redsense Medical AB

Healthcare Medical Devices Stockholm Exchange
3.43 SEK
Close of Oct 16, 2026
2.40 5.70
Market cap
SEK 56.4M
P/E
-
P/B
1.65x
ROE
8.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is REDS.ST undervalued?

Graham number

The Graham number of Redsense Medical AB cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Redsense Medical AB fundamental analysis

No fundamental analysis for Redsense Medical AB yet.

Redsense Medical AB stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Redsense Medical AB

Redsense Medical AB (publ) provides an alarm in the event of blood leakage to monitor hemodialysis treatments in Europe, Canada, and Australia. It offers alarm units, such as Redsense, an alarm system for monitoring the blood access during hemodialysis; sensor patches to monitor venous needle or catheter access; and Redsense clamps to automatically stop the blood flow. The company was founded in 2000 and is headquartered in Halmstad, Sweden.

Full company profile